Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 29 peer-reviewed journal articles Updated
Pulmonology · Pulmonary Aspergillosis

Aspergillus Niger: Do I Need Bronchoscopy, BAL, or Biopsy?

At a Glance

A positive Aspergillus niger sputum culture does not by itself prove an active lung infection or require an invasive procedure. Bronchoscopy with BAL or a biopsy is considered when other tests are unclear, illness is severe, or tissue confirmation could change treatment.

A positive sputum culture for Aspergillus niger does not automatically mean you need a bronchoscopy or lung biopsy [1]. Aspergillus spores are commonly inhaled, and finding the fungus in the sputum or phlegm coughed up from your lungs might just mean it is living in your airways without causing an active infection (a state called colonization) [1] [2].

If your doctor suspects an infection, they will often first rely on your medical history, immune status, a chest CT scan, and blood tests. The appropriate noninvasive tests depend on your suspected condition:

  • Chronic Pulmonary Aspergillosis (CPA): This usually affects people with underlying lung diseases (like COPD) but a normal immune system. Doctors look for Aspergillus-specific IgG antibodies in the blood, along with chronic symptoms and lung cavities on a CT scan [3] [4].
  • Invasive Pulmonary Aspergillosis (IPA): This severe infection typically affects people with highly compromised immune systems (like those undergoing chemotherapy or a stem cell transplant). Doctors may use a serum galactomannan (GM) test, which looks for a substance released by the growing fungus [5] [6].

It is important to know that a negative blood test does not completely rule out an infection, and a single positive test does not guarantee you have one [7] [8]. Invasive procedures like a bronchoscopy or biopsy are considered when noninvasive tests do not provide a clear answer, your symptoms are severe, or confirming the diagnosis will significantly change your treatment plan [5] [9].

When is a Bronchoscopy and BAL Needed?

A bronchoscopy involves passing a thin, flexible tube with a camera through your nose or mouth into your airways. During this procedure, the doctor often performs a bronchoalveolar lavage (BAL). This means squirting a small amount of sterile saltwater into a section of the lung and sucking it back out to collect a fluid sample from deep within the lungs [8].

While a BAL fluid sample can be contaminated or simply reflect colonization, it often provides more targeted diagnostic clues than a regular sputum sample in high-risk patients [8]. A BAL may be recommended to:

  • Test for Galactomannan (GM): In high-risk, immunocompromised patients, testing BAL fluid for GM can sometimes be more sensitive than blood tests for detecting invasive disease [10] [8].
  • Look for Fungal DNA (PCR): PCR tests look for the genetic material of the fungus. They are most useful when combined with GM testing to support a diagnosis [11].
  • Perform Microscopy and Culture: The lab will look for fungal elements and attempt to grow the fungus. While growing it (culture) does not prove the fungus has invaded your lung tissue, it can help confirm the exact species (Aspergillus niger) and allow doctors to test which antifungal medications will work best [12] [13].
  • Examine the Cells (Cytology): Looking at the cells under a microscope can sometimes reveal fungal hyphae (branching filaments), which adds evidence for an infection [14].

A BAL is particularly useful if your immune system is compromised, or if you are critically ill in the intensive care unit and your symptoms are not improving [5]. It can also help determine if a completely different infection (like another fungus or bacteria) is causing your symptoms [15].

When is a Lung Biopsy Needed?

A lung biopsy removes a physical piece of lung tissue. This can be done through the bronchoscope (transbronchial biopsy), with a needle through the chest wall guided by a CT scan (percutaneous biopsy), or through surgery [16] [17].

Because a biopsy carries higher risks, it is not always required. In fact, doctors frequently diagnose and treat “probable” invasive pulmonary aspergillosis without a biopsy if your immune risk, CT scan, and BAL or blood tests strongly suggest the disease [18]. However, direct tissue evidence of fungal hyphae invading the lung tissue is the basis for a formal “proven” diagnosis [16] [19].

Your doctor may recommend a biopsy if:

  • Cancer or another disease is a possibility: Sometimes Aspergillus creates nodules or masses that look like lung cancer or inflammatory diseases on a CT scan. A biopsy can help distinguish between these conditions if the result will change your treatment [20].
  • Tests are negative but suspicion is high: If you are severely immunocompromised and have concerning lung nodules, but your blood and BAL tests are negative, a biopsy might provide a definitive answer [16].

What to Expect: Preparation, Sedation, and Risks

The decision to perform these procedures involves carefully weighing the need for a diagnosis against the physical risks [9].

  • Preparation: Before the procedure, you will be asked to fast (usually for several hours). Your doctor will review your medications, especially blood thinners, to see if any need to be paused. You will also need to arrange a ride home if sedation is used.
  • Sedation: Depending on the exact procedure and your hospital’s practices, bronchoscopy can be done using topical numbing medicine alone, moderate intravenous (IV) sedation to keep you relaxed, or even general anesthesia [21] [22]. Most people breathe independently with continuous monitoring, but oxygen or airway support may be needed [21].
  • BAL Risks: Bronchoscopy with BAL is generally safe, but risks include a temporary drop in oxygen levels (especially if you have severe COPD or are critically ill), airway spasms (bronchospasm), heart rhythm changes, and a mild sore throat or cough afterward [23] [24].
  • Biopsy Risks: Taking a tissue sample has significantly higher risks than a BAL alone. Transbronchial and CT-guided percutaneous biopsies carry risks of bleeding in the airways and a collapsed lung (pneumothorax), which sometimes requires a chest tube to drain the air [25] [26]. Because of these risks, biopsies are carefully considered and may be avoided or delayed if your blood does not clot well or if your lung function is severely poor [27] [28].

When to Seek Urgent Help

Do not wait for a procedure if your symptoms are severe. Seek urgent medical attention if you experience rapidly worsening breathlessness, low oxygen readings, coughing up more than a small streak of blood, chest pain, confusion, or a high fever—especially if your immune system is compromised. In highly suspicious or severe cases, your doctor may start life-saving antifungal treatment immediately, even before a bronchoscopy or biopsy can be performed or before the final results return [29] [5].

Common questions in this guide

Does a positive Aspergillus niger sputum culture mean I need a bronchoscopy?
No. Aspergillus can live in the airways without causing active infection, a situation called colonization. Doctors consider your symptoms, immune status, CT findings, and blood tests before deciding whether bronchoscopy or another invasive test is needed.
When can a BAL help diagnose Aspergillus lung disease?
A bronchoalveolar lavage, or BAL, collects fluid from deeper in the lungs during bronchoscopy. It may be especially useful when a person is immunocompromised, critically ill, or not improving, because the sample can be tested for fungal markers, genetic material, fungal growth, and cells.
When is a lung biopsy recommended for suspected Aspergillus infection?
A biopsy may be considered when cancer or another lung disease could look similar on a CT scan, or when other tests are negative but suspicion remains high. It provides tissue that can show fungus invading the lung, but it carries more risk than BAL alone.
What are the risks of bronchoscopy with BAL or a lung biopsy?
Bronchoscopy with BAL can temporarily lower oxygen levels and may cause airway tightening, heart rhythm changes, a sore throat, or coughing. Biopsy adds risks such as bleeding and a collapsed lung, so doctors weigh the possible diagnostic benefit against your lung function, blood-clotting status, and overall health.
Can antifungal treatment start before bronchoscopy or biopsy results are available?
Yes, in severe or highly suspicious cases, clinicians may begin antifungal treatment before a procedure or final results return. The decision depends on the severity of illness, immune status, CT findings, and the balance between treatment benefits and risks.
What symptoms mean I should seek urgent help?
Seek urgent medical care for rapidly worsening breathlessness, low oxygen readings, more than a small streak of blood when coughing, chest pain, confusion, or high fever. These warning signs are especially important if your immune system is suppressed.

Related questions

Why Does Aspergillus niger Ear Infection Keep Returning? How Long Does Aspergillus niger Ear Infection Take to Heal? What Does CT Show in Chronic vs. Invasive Aspergillosis? Aspergillus Niger Ear Drops: Safe With Tubes or Perforation? How to Prevent Recurrent Aspergillus niger Ear Infections
Show more
Are Ear Drops, Peroxide, or Oil Safe for Aspergillus niger? Can Black Mold Cause an Aspergillus niger Infection? How Can Aspergillus Otomycosis Resemble Bacteria or Eczema? Aspergillus Ear Infection: Oral Antifungals or Surgery? How Common Is Aspergillus niger Compared With A. fumigatus? How Do Lung Diseases Raise Aspergillus niger Risk? How Does Aspergillus Niger Infection Affect Daily Life? Positive Aspergillus niger Culture: Is Normal CT Reassuring? Can Healthy People Get Aspergillus niger Lung Infection? Can Alcohol or Supplements Affect Aspergillus Treatment? Can Aspergillus niger Be Mistaken for A. tubingensis? Can Aspergillus niger Otomycosis Cause Permanent Ear Damage? Is Aspergillus niger Contagious? Can It Spread Person-to-Person? What Is the Prognosis for Aspergillus niger Infections?

Get notified when new evidence is published on Aspergillus niger infection.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (29)
  1. 1

    [Aspergillus in airway material : Ignore or treat?]

    Salzer HJF, Lange C, Hönigl M

    Der Internist 2017; (58(11)):1150-1162 doi:10.1007/s00108-017-0334-9.

    PMID: 28986661
  2. 2

    Species-specific detection of medically important aspergilli by a loop-mediated isothermal amplification method in chronic pulmonary aspergillosis.

    Tone K, Suzuki J, Alshahni MM, et al.

    Medical mycology 2019; (57(6)):703-709 doi:10.1093/mmy/myy128.

    PMID: 30649423
  3. 3

    Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management.

    Denning DW, Cadranel J, Beigelman-Aubry C, et al.

    The European respiratory journal 2016; (47(1)):45-68 doi:10.1183/13993003.00583-2015.

    PMID: 26699723
  4. 4

    Chronic Pulmonary Aspergillosis: Notes for a Clinician in a Resource-Limited Setting Where There Is No Mycologist.

    Bongomin F, Asio LG, Baluku JB, et al.

    Journal of fungi (Basel, Switzerland) 2020; (6(2)) doi:10.3390/jof6020075.

    PMID: 32498415
  5. 5

    [Expert consensus on the diagnosis and treatment of pulmonary aspergillosis in patients with chronic obstructive pulmonary disease].

    Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases 2024; (47(7)):604-622 doi:10.3760/cma.j.cn112147-20231228-00399.

    PMID: 38955746
  6. 6

    Serology anno 2021-fungal infections: from invasive to chronic.

    Lass-Flörl C, Samardzic E, Knoll M

    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2021; (27(9)):1230-1241 doi:10.1016/j.cmi.2021.02.005.

    PMID: 33601011
  7. 7

    A 10-year study reveals clinical and laboratory evidence for the 'semi-invasive' properties of chronic pulmonary aspergillosis.

    Chan JF, Lau SK, Wong SC, et al.

    Emerging microbes & infections 2016; (5()):e37 doi:10.1038/emi.2016.31.

    PMID: 27094904
  8. 8

    Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis.

    Verweij PE, Brüggemann RJM, Azoulay E, et al.

    Intensive care medicine 2021; (47(8)):819-834 doi:10.1007/s00134-021-06449-4.

    PMID: 34160631
  9. 9

    Invasive Pulmonary Aspergillosis in Coronavirus Disease 2019 Patients Lights and Shadows in the Current Landscape.

    Tsotsolis S, Kotoulas SC, Lavrentieva A

    Advances in respiratory medicine 2023; (91(3)):185-202 doi:10.3390/arm91030016.

    PMID: 37218799
  10. 10

    Diagnostic Value of Galactomannan Antigen Test in Serum and Bronchoalveolar Lavage Fluid Samples from Patients with Nonneutropenic Invasive Pulmonary Aspergillosis.

    Zhou W, Li H, Zhang Y, et al.

    Journal of clinical microbiology 2017; (55(7)):2153-2161 doi:10.1128/JCM.00345-17.

    PMID: 28446576
  11. 11

    Diagnostic role of polymerase chain reaction in bronchoalveolar lavage fluid for invasive pulmonary aspergillosis in immunocompromised patients - A retrospective cohort study.

    Hardak E, Fuchs E, Leskes H, et al.

    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2019; (83()):20-25 doi:10.1016/j.ijid.2019.03.025.

    PMID: 30926540
  12. 12

    Laboratory Diagnostics of Aspergillosis: Present State and Future Directions.

    Tomazin R, Matos T

    Journal of fungi (Basel, Switzerland) 2026; (12(5)) doi:10.3390/jof12050379.

    PMID: 42187861
  13. 13

    Diagnosis of invasive pulmonary fungal infections by a real-time panfungal PCR assay in non-neutropenic patients.

    Chen F, Chen Y, Chi Y, et al.

    Medicine 2023; (102(51)):e36385 doi:10.1097/MD.0000000000036385.

    PMID: 38134111
  14. 14

    Aspergillus hubkae, a Novel Species Isolated from a Patient with Probable Invasive Pulmonary Aspergillosis.

    Zhou YB, Rezaei-Matehkolaei A, Meijer M, et al.

    Mycopathologia 2024; (189(3)):44 doi:10.1007/s11046-024-00848-z.

    PMID: 38734862
  15. 15

    Non-invasive monitoring of Aspergillus infections in chronic lung disease patients: a combined serology and HRCT imaging approach.

    Zhang R, Yang L, Fang H, et al.

    Frontiers in cellular and infection microbiology 2025; (15()):1494522 doi:10.3389/fcimb.2025.1494522.

    PMID: 40654578
  16. 16

    Invasive Aspergillosis Masquerading as Multiple Pulmonary Nodules: A Challenging Diagnosis.

    Chhabria M, Venugopal S, Pendela VS, Jadhav N

    Cureus 2020; (12(5)):e8186 doi:10.7759/cureus.8186.

    PMID: 32566427
  17. 17

    Solitary Lung Nodule: CT-Guided Transthoracic Biopsy vs Transbronchial Biopsy With Endobronchial Ultrasound and Flexible Bronchoscope, a Meta-Analysis of Randomized Controlled Trials.

    Ho ATN, Gorthi R, Lee R, et al.

    Lung 2023; (201(1)):85-93 doi:10.1007/s00408-023-00596-9.

    PMID: 36695890
  18. 18

    Comparison of four diagnostic criteria for invasive pulmonary aspergillosis-A diagnostic accuracy study in critically ill patients.

    Schroeder M, Giese M, Wijaya C, et al.

    Mycoses 2022; (65(8)):824-833 doi:10.1111/myc.13478.

    PMID: 35661434
  19. 19

    Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion.

    Verweij PE, Rijnders BJA, Brüggemann RJM, et al.

    Intensive care medicine 2020; (46(8)):1524-1535 doi:10.1007/s00134-020-06091-6.

    PMID: 32572532
  20. 20

    Airway-centered invasive pulmonary aspergillosis featuring histopathologic fruiting bodies in an immunocompetent patient with a rare incidental finding of thyroid gland Schwannoma: a case report.

    Majeed I, Aziz S, Khan ZR, Arnold F

    BMC infectious diseases 2025; (25(1)):344 doi:10.1186/s12879-025-10694-z.

    PMID: 40069656
  21. 21

    [Anaesthesiological Concepts in Interventional Bronchoscopy - Current Strategies and Anaesthesiological Challenges].

    Semmelmann A, Loop T

    Zentralblatt fur Chirurgie 2026; (151(S 01)):S46-S59 doi:10.1055/a-2791-8690.

    PMID: 41713849
  22. 22

    A survey of flexible bronchoscopy practices in India: The Indian bronchoscopy survey (2017).

    Madan K, Mohan A, Agarwal R, et al.

    Lung India : official organ of Indian Chest Society 2018; (35(2)):98-107 doi:10.4103/lungindia.lungindia_417_17.

    PMID: 29487243
  23. 23

    Risk Factors for Predicting Hypoxia in Adult Patients Undergoing Bronchoscopy under Sedation.

    Choi JS, Lee EH, Lee SH, et al.

    Tuberculosis and respiratory diseases 2020; (83(4)):276-282 doi:10.4046/trd.2020.0002.

    PMID: 32640767
  24. 24

    Bronchoscopy Safety in Patients With Chronic Obstructive Lung Disease.

    Bellinger CR, Khan I, Chatterjee AB, Haponik EF

    Journal of bronchology & interventional pulmonology 2017; (24(2)):98-103 doi:10.1097/LBR.0000000000000333.

    PMID: 28005831
  25. 25

    Iatrogenic bleeding during flexible bronchoscopy: risk factors, prophylactic measures and management.

    Bernasconi M, Koegelenberg CFN, Koutsokera A, et al.

    ERJ open research 2017; (3(2)) doi:10.1183/23120541.00084-2016.

    PMID: 28656131
  26. 26

    Predictive risk factors for pneumothorax following fluoroscopic-guided transbronchial lung biopsy.

    Ng BH, Low HJ, Nuratiqah NA, et al.

    The Medical journal of Malaysia 2023; (78(7)):897-900.

    PMID: 38159925
  27. 27

    Bronchoalveolar lavage and lung biopsy in patients with cancer and hematopoietic stem-cell transplantation recipients: a systematic review and meta-analysis.

    Chellapandian D, Lehrnbecher T, Phillips B, et al.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2015; (33(5)):501-9 doi:10.1200/JCO.2014.58.0480.

    PMID: 25559816
  28. 28

    Image-guided biopsy in primary lung cancer: Why, when and how.

    de Margerie-Mellon C, de Bazelaire C, de Kerviler E

    Diagnostic and interventional imaging 2016; (97(10)):965-972 doi:10.1016/j.diii.2016.06.016.

    PMID: 27481575
  29. 29

    Unmasking Invasive Pulmonary Aspergillosis: Insights From a Case Series at a Tertiary Care Center.

    Munasinghe K, Nanayakkara AM, De Zoysa W, et al.

    Cureus 2025; (17(12)):e100065 doi:10.7759/cureus.100065.

    PMID: 41583184

This page is for informational purposes only and does not constitute medical advice. A pulmonologist or infectious-disease clinician should assess your symptoms, test results, immune status, and procedure risks.